| Jane Marie Testa, | |
|
1000 Montauk Hwy, West Islip, NY 11795-4927 | |
| (631) 376-4027 | |
| Not Available |
| Full Name | Jane Marie Testa |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 30 Years |
| Location | 1000 Montauk Hwy, West Islip, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477599165 | NPI | - | NPPES |
| 02187933 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 216627 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Suny/stony Brook University Hospital | Stony brook, NY | Hospital |
| Long Island Community Hospital | Patchogue, NY | Hospital |
| Upmc Chautauqua At Wca | Jamestown, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York University | 1355232422 | 4431 |
| Upmc Chautauqua At Wca | 4385630342 | 19 |
| Stony Brook Radiology, University Faculty Practice Corporation | 4587555198 | 63 |
News Archive
New research determined that an increase in the severity of hallux valgus, or bunion deformity, progressively reduced both general and foot-specific health related quality of life (HRQOL). Bunion deformity was found in 36% of the study population and occurred more frequently in women and older individuals.
The U.S. Food and Drug Administration today expanded the approved use of Dexcom's G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose (sugar) testing for diabetes treatment decisions in people 2 years of age and older with diabetes.
Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have limited utility suppressing the metastatic spread of cancer cells. microRNA therapeutics targeting miR-10b represent a promising approach for the discovery and development of a novel anti-metastatic agent.
Most women who are born with heart defects can safely become pregnant and give birth to healthy babies with few or minor problems if they are supported by expert medical care and counselling, according to research published in the European Heart Journal .
› Verified 7 days ago
| Entity Name | Stony Brook Radiology, University Faculty Practice Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366497448 PECOS PAC ID: 4587555198 Enrollment ID: O20040323001029 |
News Archive
New research determined that an increase in the severity of hallux valgus, or bunion deformity, progressively reduced both general and foot-specific health related quality of life (HRQOL). Bunion deformity was found in 36% of the study population and occurred more frequently in women and older individuals.
The U.S. Food and Drug Administration today expanded the approved use of Dexcom's G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose (sugar) testing for diabetes treatment decisions in people 2 years of age and older with diabetes.
Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have limited utility suppressing the metastatic spread of cancer cells. microRNA therapeutics targeting miR-10b represent a promising approach for the discovery and development of a novel anti-metastatic agent.
Most women who are born with heart defects can safely become pregnant and give birth to healthy babies with few or minor problems if they are supported by expert medical care and counselling, according to research published in the European Heart Journal .
› Verified 7 days ago
| Entity Name | Upmc Chautauqua At Wca |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295033298 PECOS PAC ID: 4385630342 Enrollment ID: O20040423000846 |
News Archive
New research determined that an increase in the severity of hallux valgus, or bunion deformity, progressively reduced both general and foot-specific health related quality of life (HRQOL). Bunion deformity was found in 36% of the study population and occurred more frequently in women and older individuals.
The U.S. Food and Drug Administration today expanded the approved use of Dexcom's G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose (sugar) testing for diabetes treatment decisions in people 2 years of age and older with diabetes.
Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have limited utility suppressing the metastatic spread of cancer cells. microRNA therapeutics targeting miR-10b represent a promising approach for the discovery and development of a novel anti-metastatic agent.
Most women who are born with heart defects can safely become pregnant and give birth to healthy babies with few or minor problems if they are supported by expert medical care and counselling, according to research published in the European Heart Journal .
› Verified 7 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20081202000185 |
News Archive
New research determined that an increase in the severity of hallux valgus, or bunion deformity, progressively reduced both general and foot-specific health related quality of life (HRQOL). Bunion deformity was found in 36% of the study population and occurred more frequently in women and older individuals.
The U.S. Food and Drug Administration today expanded the approved use of Dexcom's G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose (sugar) testing for diabetes treatment decisions in people 2 years of age and older with diabetes.
Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have limited utility suppressing the metastatic spread of cancer cells. microRNA therapeutics targeting miR-10b represent a promising approach for the discovery and development of a novel anti-metastatic agent.
Most women who are born with heart defects can safely become pregnant and give birth to healthy babies with few or minor problems if they are supported by expert medical care and counselling, according to research published in the European Heart Journal .
› Verified 7 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
New research determined that an increase in the severity of hallux valgus, or bunion deformity, progressively reduced both general and foot-specific health related quality of life (HRQOL). Bunion deformity was found in 36% of the study population and occurred more frequently in women and older individuals.
The U.S. Food and Drug Administration today expanded the approved use of Dexcom's G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose (sugar) testing for diabetes treatment decisions in people 2 years of age and older with diabetes.
Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have limited utility suppressing the metastatic spread of cancer cells. microRNA therapeutics targeting miR-10b represent a promising approach for the discovery and development of a novel anti-metastatic agent.
Most women who are born with heart defects can safely become pregnant and give birth to healthy babies with few or minor problems if they are supported by expert medical care and counselling, according to research published in the European Heart Journal .
› Verified 7 days ago
| Entity Name | Radiology Advantage New Jersey Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922495787 PECOS PAC ID: 1153649686 Enrollment ID: O20150908002153 |
News Archive
New research determined that an increase in the severity of hallux valgus, or bunion deformity, progressively reduced both general and foot-specific health related quality of life (HRQOL). Bunion deformity was found in 36% of the study population and occurred more frequently in women and older individuals.
The U.S. Food and Drug Administration today expanded the approved use of Dexcom's G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose (sugar) testing for diabetes treatment decisions in people 2 years of age and older with diabetes.
Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have limited utility suppressing the metastatic spread of cancer cells. microRNA therapeutics targeting miR-10b represent a promising approach for the discovery and development of a novel anti-metastatic agent.
Most women who are born with heart defects can safely become pregnant and give birth to healthy babies with few or minor problems if they are supported by expert medical care and counselling, according to research published in the European Heart Journal .
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jane Marie Testa, Po Box 6010, Hauppauge, NY 11788-9010 Ph: (631) 232-4000 | Jane Marie Testa, 1000 Montauk Hwy, West Islip, NY 11795-4927 Ph: (631) 376-4027 |
News Archive
New research determined that an increase in the severity of hallux valgus, or bunion deformity, progressively reduced both general and foot-specific health related quality of life (HRQOL). Bunion deformity was found in 36% of the study population and occurred more frequently in women and older individuals.
The U.S. Food and Drug Administration today expanded the approved use of Dexcom's G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose (sugar) testing for diabetes treatment decisions in people 2 years of age and older with diabetes.
Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have limited utility suppressing the metastatic spread of cancer cells. microRNA therapeutics targeting miR-10b represent a promising approach for the discovery and development of a novel anti-metastatic agent.
Most women who are born with heart defects can safely become pregnant and give birth to healthy babies with few or minor problems if they are supported by expert medical care and counselling, according to research published in the European Heart Journal .
› Verified 7 days ago
William M Kainzbauer, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Montauk Highway, West Islip, NY 11795 Phone: 952-595-1100 Fax: 612-294-4903 | |
Asaph Zimmerman, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Montauk Hwy, West Islip, NY 11795 Phone: 952-595-1100 Fax: 612-294-4903 | |
Brian J Webber, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Montauk Hwy, Department Of Radiology, Good Samaritan Hospital, West Islip, NY 11795 Phone: 952-595-1100 Fax: 612-294-4903 | |
Shu-ho Chang, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Montauk Hwy, Good Samaritan Hospital, West Islip, NY 11795 Phone: 952-595-1100 Fax: 612-294-4903 | |
Dr. David Pfeffer, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Montauk Hwy, West Islip, NY 11795 Phone: 952-595-1301 Fax: 612-294-4903 | |
Michael Christopher Hill, MBBCH Radiology Medicare: Medicare Enrolled Practice Location: 1000 Montauk Highway, West Islip, NY 11795 Phone: 631-376-4027 | |
Dr. Hakeem Afuwape, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Montauk Hwy, West Islip, NY 11795 Phone: 631-376-4027 |